ZNTL
NASDAQ · Biotechnology
Zentalis Pharmaceuticals Inc
$2.29
+0.15 (+7.01%)
Open$2.23
Previous Close$2.14
Day High$2.33
Day Low$2.18
52W High$3.95
52W Low$1.01
Volume—
Avg Volume424.1K
Market Cap195.18M
P/E Ratio—
EPS$-2.08
SectorBiotechnology
Analyst Ratings
Buy
15 analysts
Price Target
+1,083.0% upside
Current
$2.29
$2.29
Target
$27.09
$27.09
$17.95
$27.09 avg
$27.14
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 72.61M | 27.61M | 25.42M |
| Net Income | -178,578,310 | -2,223,610 | -1,538,415 |
| Profit Margin | -246.0% | -8.1% | -6.1% |
| EBITDA | -204,495,165 | -3,072,165 | -2,609,903 |
| Free Cash Flow | — | -1,433,660 | -1,157,693 |
| Rev Growth | — | +21.3% | +16.0% |
| Debt/Equity | — | 0.13 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $214.87 | -1.20% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $354.05 | +0.63% | 24.7 | 190.40B |
| GILD | Gilead Sciences Inc | $140.73 | +0.98% | 19.6 | 166.66B |
| VRTX | Vertex Pharmaceuticals Inc | $449.71 | +0.71% | 29.1 | 114.87B |
| REGN | Regeneron Pharmaceuticals | $776.21 | +0.46% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $330.87 | +4.68% | 139.7 | 43.84B |